PKR-dependent mechanisms of interferon-α for inhibiting hepatitis B virus replication

被引:24
|
作者
Park, Il-Hyun [1 ]
Baek, Kyung-Won [1 ]
Cho, Eun-Young [1 ]
Ahn, Byung-Yoon [1 ]
机构
[1] Korea Univ, Sch Life Sci & Biotechnol, Seoul 136701, South Korea
关键词
antiviral mechanism; Hepatitis B virus; IFN-alpha; PKR; HUMAN HEPATOMA-CELLS; GENE-EXPRESSION; TRANSGENIC MICE; PROTEIN; RNA; NUCLEOCAPSIDS; ACTIVATION; DNA;
D O I
10.1007/s10059-011-1059-6
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Interferon-alpha (IFN-alpha) inhibits the replication of hepatitis B virus (HBV) in vivo and in vitro, but the molecular mechanism of this inhibition has been elusive. We found that while HBV replication in transfected human hepatoma Huh-7 cell was severely inhibited by IFN-alpha treatment as reported previously, this inhibition was markedly impaired in the cell in which the expression of IFN-inducible, double-stranded RNA-dependent protein kinase (PKR) was stably and specifically suppressed through RNA-interference. Intracellular level of viral capsids was down-regulated likewise in a PKR-dependent manner, whereas that of HBV transcripts including the viral RNA pregenome was not affected by IFN-alpha treatment. Ectopic expression of PKR also resulted in the reduction of viral capsids with concomitant increase of phosphorylated eIF2 alpha. These results suggested that PKR functions as a key mediator of IFN-alpha in opposing HBV replication, most likely through the inhibition of protein synthesis.
引用
收藏
页码:167 / 172
页数:6
相关论文
共 50 条
  • [31] Construction of a replication-competent hepatitis B virus vector carrying secreted luciferase transgene and establishment of new hepatitis B virus replication and expression cell lines
    Ruan, Jie
    Ping, Cai-Yan
    Sun, Shuo
    Cheng, Xin
    Han, Peng-Yu
    Zhang, Yin-Ge
    Sun, Dian-Xing
    WORLD JOURNAL OF GASTROENTEROLOGY, 2019, 25 (39) : 5961 - 5972
  • [32] Alpha-enolase regulates hepatitis B virus replication through suppression of the interferon signalling pathway
    Xiang-Chun, D.
    Xiao-qing, Y.
    Ting-Ting, Y.
    Zhen-Hui, L.
    Xiao-Yan, L.
    Xia, L.
    Yan-Chao, H.
    Yi-Xuan, Y.
    Li-Na, M.
    JOURNAL OF VIRAL HEPATITIS, 2018, 25 (03) : 289 - 295
  • [33] Hepatitis E virus-encoded microRNA promotes viral replication by inhibiting type I interferon
    Qian, Zhongyao
    Yang, Chenchen
    Xu, Liangheng
    Mickael, Houfack K.
    Chen, Shuangfeng
    Zhang, Yike
    Xia, Yueping
    Li, Tengyuan
    Yu, Wenhai
    Huang, Fen
    FASEB JOURNAL, 2022, 36 (01)
  • [34] Suppression of Interferon-α Treatment Response by Host Negative Factors in Hepatitis B Virus Infection
    Wang, Jiayi
    Du, Lingyao
    Tang, Hong
    FRONTIERS IN MEDICINE, 2021, 8
  • [35] The in vitro replication phenotype of hepatitis B virus (HBV) splice variant Sp1
    Sozzi, V.
    McCoullough, L.
    Mason, H.
    Littlejohn, M.
    Revill, P. A.
    VIROLOGY, 2022, 574 : 65 - 70
  • [36] Inhibition of duck hepatitis B virus replication by mimic peptides in vitro
    Jia, Hongyu
    Liu, Changhong
    Yang, Ying
    Zhu, Haihong
    Chen, Feng
    Liu, Jihong
    Zhou, Linfu
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2015, 10 (05) : 1697 - 1703
  • [37] Interferon stimulated exonuclease gene 20 kDa promotes the activity of interferon-alpha on the inhibition of hepatitis B virus replication via its exonuclease activity
    Ma, Qian
    Qin, Bo
    Lu, Xi
    Kong, Lingna
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9 (09): : 17940 - 17945
  • [38] Combination Therapy of Active HBsAg Vaccination and Interferon-α in Interferon-α Nonresponders with Chronic Hepatitis B
    Tobias Heintges
    Wolfgang Petry
    Michaela Kaldewey
    Andreas Erhardt
    Ulrike C. Wend
    Wolfram H. Gerlich
    Claus Niederau
    Dieter Hãussinger
    Digestive Diseases and Sciences, 2001, 46 : 901 - 906
  • [39] Hepatitis B virus genome replication triggers toll-like receptor 3-dependent interferon responses in the absence of hepatitis B surface antigen
    Real, Catherine Isabell
    Lu, Mengji
    Liu, Jia
    Huang, Xuan
    Trippler, Martin
    Hossbach, Markus
    Deckert, Jochen
    Jahn-Hofmann, Kerstin
    Ickenstein, Ludger Markus
    John, Matthias Johannes
    Gibbert, Kathrin
    Dittmer, Ulf
    Vornlocher, Hans-Peter
    Schirmbeck, Reinhold
    Gerken, Guido
    Schlaak, Joerg Friedrich
    Broering, Ruth
    SCIENTIFIC REPORTS, 2016, 6
  • [40] Combination therapy of active HBsAg vaccination and interferon-α in interferon-α nonresponders with chronic hepatitis B
    Heintges, T
    Petry, W
    Kaldewey, M
    Erhardt, A
    Wend, UC
    Gerlich, WH
    Niederau, C
    Häussinger, D
    DIGESTIVE DISEASES AND SCIENCES, 2001, 46 (04) : 901 - 906